CATUG Biotechnology is a forward-thinking provider of Contract Development and Manufacturing Organisation (CDMO) services, focusing on mRNA vaccines and therapeutics, as well as gene and cell therapy (GCT). The company prides itself on its four fundamental technology platforms: plasmid, mRNA, lipid nanoparticle (LNP), and analytical quality control (QC). CATUG aims to offer end-to-end solutions throughout the life cycle of mRNA therapeutics and GCT product development, delivering customised services and innovative solutions tailored to each client’s specific needs and timelines.

Services include:
- mRNA vaccine development
- Gene and cell therapy product development
- Plasmid DNA production
- Lipid nanoparticle formulation
- Analytical quality control services

CATUG is dedicated to supporting clients in the pharmaceutical industry with a comprehensive range of services designed to advance the development of cutting-edge therapeutics. To learn more about their innovative offerings, visit catug.bio.